ABSTRACT. The host immune system has been documented to influence the course and outcome of infection with the phospholipase-Cdeficient (PLC 
Despite being an ancient disease, there is no effective control against African trypanosomosis, mainly due to antigenic variation and the limited success in vector control [20] . Thus future control strategies against this infection should target the disease process rather than the parasite itself. In particular, identification of immunological mechanisms responsible for host resistance to African trypanosome infection could suggest interventions that might lead to sustainable disease control.
Laboratory rodents on different genetic backgrounds exhibit different phenotypes upon infection with African trypanosomes. For instance, C3H and AKR (H-2 k ) are among the most susceptible mice to Trypanosoma brucei (T. brucei) species, while B10.Br (also H-2 k ) and C57BL/6 (H-2 b ) are relatively resistant [3, 16] . Furthermore, BALB/c (H-2 d ) and A/J (H-2a) are extremely susceptible to T. congolense infection while C57BL/6 mice present a resistant phenotype [11] .
Various animal model systems have provided conflicting evidence regarding the immunological factors that influence the magnitude of resistance to African trypanosomosis [6, 15, 18] . The overall host response to this disease requires the contribution of variant-specific surface glycoprotein (VSG)-specific B and T cell responses [17] , and the macrophage/monocyte phagocyte system [19] in order to resolve the infection. Antibody (Ab) response against parasite antigens has been suggested to be critical for the development of trypanotolerance and that relative resistant mouse strains mount significantly higher Ab titers than susceptible ones [1, 9] . In addition, several studies indicate that type I cytokines (interferon [IFN]-γ, interleukin [IL]-12, tumor necrosis factor [TNF]-α) and classically-activated macrophages (caMø) [4, 10] as well as type-II cytokines (IL-4, IL-10) and alternatively-activated macrophages (aaMø) [14] , contribute towards trypanotolerance through different mechanisms.
In a previous study, using mice with identical genetic background infected with closely related wild type (WT) and null mutant phospholipase C (PLC -/-) T. b.brucei, we showed that resistance to infection correlated with absence of suppressive cells inhibiting mitogen-induced T cell proliferation in the lymph nodes, an increased production of IL-10 and IL-4 and a stronger IgG1 antibody response to VSG [13] . To further gain insights into the mechanisms of trypanotolerance, we evaluated the VSG-specific cytokine secretion in trypanotolerant B6B-F1 and relatively susceptible C3H mice upon infection with PLC -/-parasites. We show that VSG-specific cytokine responses associated with resistance to murine African trypanosomosis are infectionstage dependent.
MATERIALS AND METHODS

Animals and parasites:
Eight-weeks old female (C57BL/ 6 × BALB/c)-F1 (B6B-F1) or C3H/HeN (C3H) (Harlon, The Netherlands) were inoculated intraperitoneally (ip) with 2 × 10 3 PLC -/-AnTat 1 T. b.brucei [23] . The mutant PLC -/-parasites were pleomorphic lines of the AnTat 1 strain obtained freshly after cyclical transmission in tsetse fly, and were not selected for expression of a given VSG [23] . Parasitemia was monitored by tail blood puncture every 2-4 days using a hemocytometer. All animal experiments were conducted in accordance with the Standards relating to the Care and Management of Experimental Animals of Free University of Brussels (VUB, Brussels, Belgium).
Experimental design: At different times post-infection (pi), cytokine, antibody, nitric oxide (NO) and arginase activity levels were analyzed in 5 infected mice. For each parameter, results were expressed as the mean response of the 5 infected animals tested individually (± SE) and compared to the same parameters assessed in 5 uninfected mice. Results are representative of at least 5 similar experiments performed. Statistical analyses were assessed using a PRISM computer program (GraphPad) to validate the data. P-values of <0.05 were considered statistically significant.
Plasma collection and cell preparation: During early (2 weeks pi), late (4 weeks pi) and chronic (5 months pi) stages of infection, blood collected by heart puncture on 20 U/ml heparin (Sigma, St. Louis, MS) was centrifuged (10, 000 × g, 10 min) and the plasma stored at -80°C until analysis. Spleen, Mesenteric and peripheral (axial and inguinal) lymph node single-cell suspensions (SPC, LNC) were prepared as previously described [2] .
Cell cultures for soluble cytokine quantification: At different times pi, 4 × 10 5 SPC or LNC from infected C3H (C3H-SPC-I, C3H-LNC-I) or B6B-F1 (B6B-SPC-I, B6B-LNC-I) mice were cultured with or without 50 µg/ml soluble AnTat 1 VSG prepared as previously described [10] . The single lot preparation of VSG was used throughout the study. LPS contamination of VSG was below the detection limit of the Kinetic-QCL LAL test (Bio-Whittaker Europe, Verviers, Belgium). SPC or LNC from uninfected mice (SPC-N, LNC-N) were used as controls. Cultures were incubated at 37°C in a humidified atmosphere containing 5% CO 2 and culture supernatants collected after 72 hr and frozen at -20°C until analysis.
Quantification of cytokines: Cytokines were quantified in the plasma or cell culture supernatants using cytokine-specific sandwich ELISA. The reagents were purchased from PharMingen Europe, Erembodegem-Aalst, Belgium (IFN-γ, IL-4, IL-10) or R&D Systems, Abingdon, UK (TNF-α) and ELISA assays performed following the manufacture's suggested protocols.
Determination of antibody isotypes: Plasma from 2-weeks-infected and uninfected mice were tested in antibody isotype-specific ELISAs for VSG reactivity as previously described [13] . Briefly, ELISA plates were coated with 5 µg/ml AnTat 1 VSG at 4°C overnight. Plates were washed (0.01% tween 20 in PBS), blocked with 10% bovine fetal calf serum in PBS (1 hr, 37°C) and washed again. Plasma samples (diluted 100 × in PBS containing 2% bovine fetal calf serum) were added to the plates (1 hr, 37°C) followed by another wash. Horseradish peroxidase conjugated ratanti-mouse isotype-specific antibodies (Southern Biotechnology, Birmingham, AL) were added (1 hr, 37°C). After washing, the assay was developed by adding 3,3',5,5'-tetramethylbenzidine (Sigma). For each sample, the optical density (OD, 490 nm) determined on bovine albumin-coated plates was subtracted from the OD values obtained on VSGcoated plates.
Determination of arginase activity: Arginase activity was measured in peripheral blood mononuclear cell (PBMC) lysates using the protocol described by Munder et al. [12] . Briefly, PBMC from heparinized venous blood of infected and noninfected mice were isolated on Ficoll-Paque (Amersham Pharmacia Biotech AB, Uppsala, Sweden) as described in [20] . Monocytes were isolated from PBMC by plastic adherence as described [2] and were lysed with 100 µl of 0.1% Triton X-100 for 30 min on a shaker. Plasma NO measurement: Levels of plasma NO were determined as nitrites as previously described [8] . Briefly, nitrate was stoichemetrically reduced to nitrite by incubating 100 µl of plasma sample for 1 hr at 37°C in presence of 0.1 U/ml of Aspergillus nitrite reductase (NAD[P]H, EC 1.6.6.2; Sigma); 120 µM reduced nicotinamide adenine dinucleotide phosphate (NADPH) and 5 µM flavine adenine dinucleotide (FAD). Subsequently, excess NADPH was oxidized with 10 U/ml L-lactic dehydrogenase (EC 1.1.1.27; type XI, from rabbit muscle; Sigma) and 10 mM sodium pyruvate (Sigma) for 30 min at 37°C. Nitrite concentration in plasma was assayed by a standard Griess reaction.
RESULTS
B6B-F1 mice are more resistant to PLC-/-T.b.brucei infection than C3H mice:
We evaluated the course of T.b.brucei infection in B6B-F1 and C3H mice. As shown in figure 1 , PLC -/-parasites induced a higher wave of parasitemia in C3H than in B6B-F1 mice. Both mouse strains cleared the first parasitemic wave. However, PLC -/--infected C3H mice were unable to control subsequent peaks of parasitemia and died with massive parasitosis about 38 days pi. On the other hand, infected B6B-F1 mice survived for more than 7 months pi. Furthermore, PLC -/--infected B6B-F1 mice had minimal clinical manifestation and reduced pathology during the course of infection as compared to C3H mice (author's unpublished observations).
PLC -/-T.b.brucei-infected B6B-F1 mice produce higher levels of VSG-specific IL-4 and IL-10 in lymph node and spleen compartments than infected C3Hmice:
We next quantified the cytokine levels in LNC-I and SPC-I culture supernatants following stimulation with VSG. There was no detectable IFN-γ, IL-4 or IL-10 in VSG-stimulated LNC-N ( Fig. 2 A-C) . In both mouse strains, VSG exclusively induced increased production of IFN-γ during early stage of infection with PLC -/-T.b.brucei. Those levels were significantly higher in C3H-LNC-I than B6B-LNC-I (p<0.05, Fig.  2A ). During late stage of infection, the production of IFN-γ by LNC from both mouse strains decreased although C3H-LNC-I continued to secrete comparatively higher amounts than B6B-LNC-I (p<0.05). In contrast, VSG-induced B6B-LNC-I produced higher quantities of IL-4 and IL-10 during late and chronic stages of infection whereas those cytokines were barely detectable in C3H-LNC-I culture supernatants (Fig. 2B-C) .
The pattern of VSG-induced cytokine secretion in the spleen compartment was generally similar to that described for the lymph node compartment ( Fig. 2A-F T.b.brucei-infected B6B-F1 and C3H mice were evaluated. As in the lymphoid compartments above (Fig. 2) , there was no detectable IFN-γ, IL-4 or IL-10 in plasma from uninfected B6B-F1 or C3H mice (Fig. 3A-C) . During early stage of infection, the PLC -/-parasites induced similar increased plasma levels of IFN-γ in B6B-F1 and C3H mice (Fig. 3A) . IFN-γ levels markedly increased in plasma from late-stage-infected C3H mice while those levels declined to basal levels during late/chronic stages of infection in B6B-F1 mice. On the other hand, plasma from infected B6B-F1 mice exhibited a progressive increase in the levels of IL-4 and IL-10 during the entire course of infection whereas those cytokines were barely detectable in the plasma from infected C3H mice (Fig. 3B-C) . 
PLC -/-T.b.brucei infection induces caMø development in both B6B-F1 and C3H mice during early stage of infection and aaMø phenotype in late/chronic-stage-infected B6B-F1
mice: Because our data so far indicate that the cytokine environments in susceptible and resistant mouse strains were different, we next investigated the phenotype of macrophages in the 2 mouse strains. TNF-α and NO levels, reflecting caMø activation, were determined in the plasma of B6B-F1 and C3H mice upon infection with PLC -/-parasites. In parallel, arginase activity, reflecting aaMø phenotype, was quantified in blood monocytes.
In both naïve mouse strains, there was hardly any detectable plasma levels of TNF-α whilst marginal plasma levels of NO (~110 µM) were detectable (Fig. 4A-B) . During early stage of infection, a tendency towards increased levels of TNF-α was recorded in plasma from C3H as compared to B6B-F1 mice. During late stage of infection, C3H mice exhibited profoundly elevated plasma TNF-α levels (P<0.01) whereas those levels declined to basal levels in B6B-F1 mice during late/chronic stages of infection (Fig.  4A) . Furthermore, compared to B6B-F1 mice, C3H mice had higher levels of NO throughout the course of infection (Fig. 4B) . Although PLC -/--infected B6B-F1 mice exhibited increased plasma NO levels during early stage of infection compared to levels in uninfected animals, those levels progressively declined during the course of infection.
No significant arginase activity could be detected in uninfected and early-stage-infected mice of both strains (Fig.  4C ). However, a progressive increase in arginase activity was elicited only in PLC -/--infected B6B-F1 mice from late stage of infection onwards.
PLC -/-T.b.brucei-infected B6B-F1 mice have higher plasma levels of VSG-specific antibodies than infected C3H
mice: Levels of Ab against AnTat 1 VSG were measured in the plasma of infected B6B-F1 and C3H mice at 2 weeks pi. Detectable levels of IgM, IgG1, IgG2a, IgG2b and IgG3 Ab isotypes were recorded in both mouse strains (Fig. 5) . Although a general tendency towards an increase in levels of all Ab isotypes was observed in the plasma from B6B-F1 mice, those mice mainly exhibited significantly higher levels of IgM and IgG1 Ab isotypes as compared to C3H mice (p<0.05).
DISCUSSION
The PLC -/-T.b.brucei has been shown to induce significantly lower parasitemia and prolonged survival in various outbred and inbred mice as compared to the equivalent WT parasite [13, 23] . However, the PLC -/-parasite kills immunocompromised mice as rapidly as WT T.b.brucei kills immunocompetent animals [13, 15] . In the present study, we showed that although PLC -/-parasites exhibits a trypanotolerant phenotype characterized by low levels of circulating parasites and prolonged survival in B6B-F1 mice, C3H mice were quite susceptible to the same parasites. These data confirm the notion that the growth rate and virulence of PLC -/-parasite are attenuated, in part through the activity of the host immune system [13] .
Since the immune system influences the outcome of PLC -/-T.b.brucei infection, mechanisms underlying resistance to African trypanosomosis were addressed, comparing the immune response to VSG in the relatively susceptible C3H mice and trypanotolerant B6B-F1 mice following infection with PLC -/-parasites. VSG-specific cytokinesecreting T cells were detected in the lymph node and spleen compartments of both mouse strains infected with the PLC -/-parasites. In PLC -/--susceptible C3H mice, VSGtriggered LNC-I and SPC-I produced high levels of IFN-γ, but no IL-4 and marginal IL-10. A similar cytokine production profile was recorded in the plasma of those mice. While VSG induced the production of type-I cytokines (IFN-γ) in both lymphoid compartments of early-stage-infected trypanotolerant B6B-F1 mice, late-and chronic-stage-infected mice exhibited a shift to the production of type-II cytokines (IL-4, IL-10). The change in cytokine environment in infected B6B-F1 mice from Mø-activating (IFN-γ) to Mø-deactivating (IL-4, IL-10) cytokines, correlated with a reduction in plasma TNF-α and NO levels.
In both infected C3H and B6B-F1 mice, the predominant type-I cytokine environment during early stage of infection apparently favored the development of caMø secreting increased amounts of TNF-α and NO. Interestingly, both mouse strains efficiently controlled the first parasitemic wave, supporting the contention that caMø and type-I cytokine environment are essential for resolving the initial and most aggressive parasitemic wave [4, [14] [15] . Furthermore, the switch from the production of type-I cytokines during early phase of the disease to the secretion of type-II cytokines with a concomitant development of aaMø, in late/ chronic-stage PLC -/--infected B6B-F1 mice, may be critical for their trypanotolerance as is the case in protection against Plasmodium and Borrelia infections [7, 21] . Since infection with this parasite initially triggers proinflammatory responses, type-II cytokines and aaMø developing during late/chronic stages of infection may play a critical role in restricting prolonged and exaggerated inflammatory responses that may lead to tissue damage and earlier mortality. Indeed, susceptible C3H mice that remained locked in a type-I cytokine environment with sustained Mø activation in a classical manner throughout infection, exhibited increased susceptibility to PLC -/-infection, characterized by generalized inflammatory reactions in the abdominal visceral organs (author's unpublished observations), massive parasitosis and earlier mortality.
The trypanotolerant B6B-F1 mice showed higher titers of anti-VSG Ab than the trypanosusceptible C3H mice. Hence our data support the long-standing notion that trypanosomespecific Ab contribute to the control of parasitemia in resistant animals [11, 22] . The relatively stronger IgG1 response observed in PLC -/--infected B6B-F1 mice could reflect elevated levels of circulating IL-4 [5] , and may be essential in the reduction of parasitemia and neutralization of parasite molecules involved in the pathology of the disease [20] . On the other hand, the inability of PLC -/--infected C3H mice to produce substantial amounts of type-II cytokines may limit their capacity to secrete Ab, resulting in impaired control of parasitemia and the putative pathological parasite molecules in late stage of infection.
In summary, this study support the contention of several workers [3, 16] that trypanosome-infected C3H mice have an immunological defect, manifested not only by suppression at the B cell clonal level, but also at the level of protective T cell and macrophage phenotypes. The present study further suggests that the production of various immune molecules during trypanosomosis is under tight control and that the protective immune response against T.b.brucei seems to be infection-stage dependent, with type-I cytokine response and caMø being critical during the early stage of infection while type-II cytokines and the emergence of aaΜø appear to be important during the late phase of the disease. Interestingly, the course of PLC -/-infection in B6B-F1 mice present striking similarities with that of the trypanotolerant N'dama cattle naturally-infected with T. congolense. These include: (i) lower parasitemia, (ii) prolonged survival, (iii) Increased type-II and decreased type-I immune response and (iv) reduced pathology and minimal clinical symptoms during the course of infection [20] . Hence the PLC -/--infected B6B-F1 mice represents a suitable model to study the course of infection and immune responses during T. congolense infection in cattle.
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